Paterez, Jonalyn R.
HRN: 24-77-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/27/2024
03/29/2024
IV
300mg
Q8hrs X 3 Doses
S/P NSVD With Perineal Laceration; Non-institutional Delivery
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes